Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VESTIGE: Dupilumab on Airway Inflammation in Asthma
NCT04400318Phase 4Completed
- Sponsor
- Sanofi
- Start
- Jun 2020
- Primary completion
- Jun 2023
- Modality
- Monoclonal Antibodies
- Countries
- 13
01
Overview
A Phase 4 trial of dupilumab in asthma, sponsored by Sanofi. Started Jun 2020; status: completed.
02
Drugs
03
Conditions
asthma
Beyond the preview
Go deeper on NCT04400318.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04400318.